2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$28.14-$0.10 (-0.35%)
Price as of Oct 22, 2026 7:30 PM EDT- $1.1BMarket Cap
- -27.38%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$28.14-$0.10 (-0.35%)
HROW | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.24 | ||
Change | +$0.17 (+0.61%) | ||
Open | $28.26 | ||
High | $28.66 | ||
Low | $27.98 | ||
Previous Close | $28.07 | ||
Volume | 524,149 | ||
30-Day Average Volume | 588,606 | ||
1-Week Change | 3.67% | ||
1-Month Change | -16.75% | ||
1-Year Change | -27.38% | ||
3-Year Change | 96.11% | ||
5-Year Change | 190.24% | ||
Fundamentals | |||
Shares Outstanding | 37.5M | ||
Total Assets | $416.8M | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | $70.6M | ||
Net Income | -$17.3M | ||
Free Cash Flow | -$10.2M | ||
EBIT | -$17.3M | ||
EBITDA | -$16.8M | ||
Net Working Capital | $127.1M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -75 | ||
Enterprise Value/Revenue | 18 | ||
P/B | 70 | ||
P/E | -61 | ||
PEG | -2 | ||
Price/Free Cash Flow | -103 | ||
Price/Operating Cash Flow | -109 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 02/08/2013 | ||
Earnings & Revenue